Patents by Inventor Jens-Peter MARSCHNER

Jens-Peter MARSCHNER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination of a CD30XCD16 antibody with a PD-1 antagonist for therapy
    Patent number: 11167029
    Abstract: Described is a combination therapy of (i) a multifunctional antibody having specificity for CD30 and CD16A and (ii) an anti-PD-1 antibody for the treatment of a tumor, in particular Hodgkin lymphoma.
    Type: Grant
    Filed: October 19, 2017
    Date of Patent: November 9, 2021
    Assignee: AFFIMED GMBH
    Inventors: Martin Treder, Uwe Reusch, Jens-Peter Marschner, Stefan Knackmuss
  • COMBINATION OF A CD30XCD16 ANTIBODY WITH A PD-1 ANTAGONIST FOR THERAPY
    Publication number: 20180085456
    Abstract: Described is a combination therapy of (i) a multifunctional antibody having specificity for CD30 and CD16A and (ii) an anti-PD-1 antibody for the treatment of a tumor, in particular Hodgkin lymphoma.
    Type: Application
    Filed: October 19, 2017
    Publication date: March 29, 2018
    Inventors: Martin TREDER, Uwe REUSCH, Jens-Peter MARSCHNER, Stefan KNACKMUSS